FutureTox: Building the road for 21st century toxicology and risk assessment practices

Toxicological Sciences

Volumn 137, Issue 2, 2014, Pages 269-277

  Rowlands, J Craig ^a   Sander, Miriam ^b   Bus, James S ^a,c  

^a DOW CHEMICAL COMPANY   (United States)

^b Page One Editorial   (United States)

^c Center for Toxicology and Mechanistic Biology Exponent   (United States)

Author keywords

In vitro and alternatives; Regulatory policy; Risk assessment

Indexed keywords

ARTICLE; DRUG INDUSTRY; EUROPE; GOVERNMENT REGULATION; HAZARD ASSESSMENT; HUMAN; OUTCOMES RESEARCH; RISK ASSESSMENT; TOXICITY TESTING; TOXICOLOGY; UNITED STATES; WORKSHOP;

IN VITRO AND ALTERNATIVES; REGULATORY/POLICY.; RISK ASSESSMENT;

CONGRESSES AS TOPIC; EUROPE; GOVERNMENT REGULATION; RISK ASSESSMENT; TOXICOLOGY; UNITED STATES;

EID: 84893357154     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kft252     Document Type: Article

References (23)

1. Arnot, J. A., Mackay, D., Parkerton, T. F., Zaleski, R. T., and Warren, C. S. (2010). Multimedia modeling of human exposure to chemical substances: The roles of food web biomagnification and biotransformation. Environ. Toxicol. Chem. 29, 45-55.
2. Basketter, D. A., Clewell, H., Kimber, I., Rossi, A., Blaauboer, B., Burrier, R., Daneshian, M., Eskes, C., Goldberg, A., Hasiwa, N., et al. (2012). A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing-t4 report*. ALTEX 29, 3-91.
3. Blaauboer, B. J., Boekelheide, K., Clewell, H. J., Daneshian, M., Dingemans, M. M., Goldberg, A. M., Heneweer, M., Jaworska, J., Kramer, N. I., Leist, M., et al. (2012). The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans. ALTEX 29, 411-425.
4. Black, M. B., Budinsky, R. A., Dombkowski, A., Cukovic, D., LeCluyse, E. L., Ferguson, S. S., Thomas, R. S., and Rowlands, J. C. (2012). Cross-species comparisons of transcriptomic alterations in human and rat primary hepatocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Sci. 127, 199-215.
5. Chesler, E. J., Miller, D. R., Branstetter, L. R., Galloway, L. D., Jackson, B. L., Philip, V. M., Voy, B. H., Culiat, C. T., Threadgill, D. W., Williams, R. W., et al. (2008). The collaborative cross at Oak Ridge National Laboratory: Developing a powerful resource for systems genetics. Mamm. Genome 19, 382-389.
6. Hardy, B., Apic, G., Carthew, P., Clark, D., Cook, D., Dix, I., Escher, S., Hastings, J., Heard, D. J., Jeliazkova, N., et al. (2012). Food for thought. A toxicology ontology roadmap. ALTEX 29, 129-137.
7. Hauschild, M. Z., Huijbregts, M., Jolliet, O., MacLeod, M., Margni, M., van de Meent, D., Rosenbaum, R. K., and McKone, T. E. (2008). Building a model based on scientific consensus for Life Cycle Impact Assessment of chemicals: The search for harmony and parsimony. Environ. Sci. Technol. 42, 7032-7037.
8. Jamei, M., Dickinson, G. L., and Rostami-Hodjegan, A. (2009). A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: A tale of 'bottom-up' vs 'topdown' recognition of covariates. Drug Metab. Pharmacokinet. 24, 53-75.
9. Judson, R. S., Kavlock, R. J., Setzer, R. W., Hubal, E. A., Martin, M. T., Knudsen, T. B., Houck, K. A., Thomas, R. S., Wetmore, B. A., and Dix, D. J. (2011). Estimating toxicity-related biological pathway altering doses for high-throughput chemical risk assessment. Chem. Res. Toxicol. 24, 451-462.
10. Judson, R. S., Martin, M. T., Egeghy, P., Gangwal, S., Reif, D. M., Kothiya, P., Wolf, M., Cathey, T., Transue, T., Smith, D., et al. (2012). Aggregating data for computational toxicology applications: The U.S. Environmental Protection Agency (EPA) Aggregated Computational Toxicology Resource (ACToR) System. Int. J. Mol. Sci. 13, 1805-1831.
11. Li, Z., Romanoff, L. C., Lewin, M. D., Porter, E. N., Trinidad, D. A., Needham, L. L., Patterson, D. G., Jr, and Sjödin, A. (2010). Variability of urinary concentrations of polycyclic aromatic hydrocarbon metabolite in general population and comparison of spot, first-morning, and 24-h void sampling. J. Expo. Sci. Environ. Epidemiol. 20, 526-535.
12. Liebsch, M., Grune, B., Seiler, A., Butzke, D., Oelgeschläger, M., Pirow, R., Adler, S., Riebeling, C., and Luch, A. (2011). Alternatives to animal testing: Current status and future perspectives. Arch. Toxicol. 85, 841-858.
13. Lock, E. F., Abdo, N., Huang, R., Xia, M., Kosyk, O., O'Shea, S. H., Zhou, Y. H., Sedykh, A., Tropsha, A., Austin, C. P., et al. (2012). Quantitative highthroughput screening for chemical toxicity in a population-based in vitro model. Toxicol. Sci. 126, 578-588.
14. National Research Council (2007). Toxicity Testing in the 21st Century: A Vision and a Strategy. The National Academies Press, Washington, DC.
15. National Research Council (2009). Science and Decisions: Advancing Risk Assessment. The National Academies Press, Washington, DC.
16. O'Shea, S. H., Schwarz, J., Kosyk, O., Ross, P. K., Ha, M. J., Wright, F. A., and Rusyn, I. (2011). In vitro screening for population variability in chemical toxicity. Toxicol. Sci. 119, 398-407.
17. Price, D. A., Blagg, J., Jones, L., Greene, N., and Wager, T. (2009). Physicochemical drug properties associated with in vivo toxicological outcomes: A review. Expert Opin. Drug Metab. Toxicol. 5, 921-931.
18. Rostami-Hodjegan, A. (2012). Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: A marriage under the arch of systems pharmacology. Clin. Pharmacol. Ther. 92, 50-61.
19. Rotroff, D. M., Wetmore, B. A., Dix, D. J., Ferguson, S. S., Clewell, H. J., Houck, K. A., Lecluyse, E. L., Andersen, M. E., Judson, R. S., Smith, C. M., et al. (2010). Incorporating human dosimetry and exposure into highthroughput in vitro toxicity screening. Toxicol. Sci. 117, 348-358.
20. Saghir, S. A., Mendrala, A. L., Bartels, M. J., Day, S. J., Hansen, S. C., Sushynski, J. M., and Bus, J. S. (2006). Strategies to assess systemic exposure of chemicals in subchronic/chronic diet and drinking water studies. Toxicol. Appl. Pharmacol. 211, 245-260.
21. Selye, H. (1956). The Stress of Life. McGraw-Hill Book Company, New York, NY.
22. Thomas, R. S., Black, M. B., Li, L., Healy, E., Chu, T. M., Bao, W., Andersen, M. E., and Wolfinger, R. D. (2012). A comprehensive statistical analysis of predicting in vivo hazard using high-throughput in vitro screening. Toxicol. Sci. 128, 398-417.
23. Wetmore, B. A., Wambaugh, J. F., Ferguson, S. S., Sochaski, M. A., Rotroff, D. M., Freeman, K., Clewell, H. J., 3rd, Dix, D. J., Andersen, M. E., Houck, K. A., et al. (2012). Integration of dosimetry, exposure, and highthroughput screening data in chemical toxicity assessment. Toxicol. Sci. 125, 157-174.